The Pharmacogenetics of Calcineurin Inhibitor-Related NephrotoxicityHESSELINK, Dennis A; BOUAMAR, Rachida; VAN GELDER, Teun et al.Therapeutic drug monitoring. 2010, Vol 32, Num 4, pp 387-393, issn 0163-4356, 7 p.Article

Relationship of Tacrolimus Exposure and Mycophenolate Mofetil Dose With Renal Function After Renal TransplantationEKBERG, Henrik; VAN GELDER, Teun; KAPLAN, Bruce et al.Transplantation. 2011, Vol 92, Num 1, pp 82-87, issn 0041-1337, 6 p.Article

Anti-interleukin-2 receptor antibodies in transplantation: What is the basis for choice?VAN GELDER, Teun; WARLE, Michiel; TER MEULEN, Rik G et al.Drugs (Basel). 2004, Vol 64, Num 16, pp 1737-1741, issn 0012-6667, 5 p.Article

Mycophenolate mofetil, Cellcept®, a new immunosuppressive drug with great potential in internal medicineGREGOOR, Peter J. H. Smak; VAN GELDER, Teun; WEIMAR, Willem et al.Netherlands journal of medicine. 2000, Vol 57, Num 6, pp 233-246, issn 0300-2977Article

Long-term survival after kidney transplantation in an HIV-positive patientROEFS, Anne; VAN DER ENDE, Marchina; IJZERMANS, Jan et al.Clinical transplantation. 2009, Vol 23, Num 2, pp 278-281, issn 0902-0063, 4 p.Article

Population pharmacokinetics of mycophenolic acid in renal transplant recipientsVAN HEST, Reinier M; VAN GELDER, Teun; VULTO, Arnold G et al.Clinical pharmacokinetics. 2005, Vol 44, Num 10, pp 1083-1096, issn 0312-5963, 14 p.Article

Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood : inhibition by immunosuppressive drugs in vitroBARTEN, Markus J; GUMMERT, Jan F; VAN GELDER, Teun et al.Journal of immunological methods. 2001, Vol 253, Num 1-2, pp 95-112, issn 0022-1759Article

The difficult diagnostic approach of the intraperitoneal mesotheliomaYOO, Sung-Min; TEN TIJE, Albert J; VAN DER HARST, Erwin et al.Netherlands journal of medicine. 2000, Vol 57, Num 6, pp 224-228, issn 0300-2977Article

The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantationVAN GELDER, Teun; SHAW, Leslie M.Transplantation. 2005, Vol 80, Num 2, pp S244-S253, issn 0041-1337, SUPArticle

Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetilVAN GELDER, Teun; TER MEULEN, Cornelis G; HENE, Ronald et al.Transplantation. 2003, Vol 75, Num 6, pp 788-791, issn 0041-1337, 4 p.Article

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acidVAN GELDER, Teun; KLUPP, Jochen; BARTEN, Markus J et al.Therapeutic drug monitoring. 2001, Vol 23, Num 2, pp 119-128, issn 0163-4356Article

Current issues in therapeutic drug monitoring of mycophenolic acid : Report of a roundtable discussionSHAW, Leslie M; HOLT, David W; OELLERICH, Michael et al.Therapeutic drug monitoring. 2001, Vol 23, Num 4, pp 305-315, issn 0163-4356Conference Paper

Unintended consequences of reducing QT-alert overload in a computerized physician order entry systemVAN DER SIJS, Heleen; KOWLESAR, Ravi; AARTS, Jos et al.European journal of clinical pharmacology. 2009, Vol 65, Num 9, pp 919-925, issn 0031-6970, 7 p.Article

Within-patient variability of mycophenolic acid exposure : Therapeutic drug monitoring from a clinical point of viewVAN HEST, Reinier M; MATHOT, Ron A; VULTO, Arnold G et al.Therapeutic drug monitoring. 2006, Vol 28, Num 1, pp 31-34, issn 0163-4356, 4 p.Article

The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ TransplantationHESSELINK, Dennis A; BOUAMAR, Rachida; ELENS, Laure et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 123-139, issn 0312-5963, 17 p.Article

Pharmacokinetic Modelling of the Plasma Protein Binding of Mycophenolic Acid in Renal Transplant RecipientsVAN HEST, Reinier M; VAN GELDER, Teun; VULTO, Arnold G et al.Clinical pharmacokinetics. 2009, Vol 48, Num 7, pp 463-476, issn 0312-5963, 14 p.Article

Yersinia pseudotuberculosis bacteraemia in a kidney transplant patientVAN ZONNEVELD, Monika; DROOGH, Joep M; FIEREN, Marien W. J. A et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, Num 12, pp 2252-2254, issn 0931-0509, 3 p.Article

Pharmacodynamics of mycophenolic acid in heart allograft recipients: Correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histologyGUMMERT, Jan F; BARTEN, Markus J; VAN GELDER, Teun et al.Transplantation. 2000, Vol 70, Num 7, pp 1038-1049, issn 0041-1337Article

Time-dependent clearance of mycophenolic acid in renal transplant recipientsVAN HEST, Reinier M; VAN GELDER, Teun; BOUW, René et al.British journal of clinical pharmacology. 2007, Vol 63, Num 6, pp 741-752, issn 0306-5251, 12 p.Article

CYP3A5 Genotype Is Not Related to the Intrapatient Variability of Tacrolimus ClearancePASHAEE, Nilufar; BOUAMAR, Rachida; HESSELINK, Dennis A et al.Therapeutic drug monitoring. 2011, Vol 33, Num 3, pp 369-371, issn 0163-4356, 3 p.Article

Clinical Utility of a New Enzymatic Assay for Determination of Mycophenolic Acid in Comparison With an Optimized LC-MS/MS MethodVAN GELDER, Teun; DOMKE, Ingrid; ENGELMAYER, Jutta et al.Therapeutic drug monitoring. 2009, Vol 31, Num 2, pp 218-223, issn 0163-4356, 6 p.Article

Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejectionKLUPP, Jochen; VAN GELDER, Teun; DAMBRIN, Camille et al.The Journal of heart and lung transplantation. 2004, Vol 23, Num 3, pp 334-351, issn 1053-2498, 18 p.Article

Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patientsVAESSEN, Leonard M. B; VAN MIERT, Paula P. M. C; VAN GELDER, Teun et al.Transplantation. 2001, Vol 71, Num 8, pp 1175-1179, issn 0041-1337Article

Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort studyVAN DER SIJS, Heleen; KOWLESAR, Ravi; KLOOTWIJK, A. Peter J et al.British journal of clinical pharmacology. 2009, Vol 67, Num 3, pp 347-354, issn 0306-5251, 8 p.Article

Page / 3